Lynne McGrath, Vice President, US DRA Head of Oncology at Novartis, presented at last year's World Orphan Drug Congress USA on the topic âA commitment to develop innovative treatments for neglected diseases.'
Do you want to learn more about:
- Setting up NIBR regardless of market size
- Expanding application to common diseases
- Transforming a promising candidate drug into a treatment reality that benefits patients
If so, you need to check out the video below: